Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 4 Issue: 2, March

The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery

Volume:4   Issue: 2
Pp: 111-124
Patrick Onyango
DOI: 10.2174/1568009043481588
Published on: 01 March, 2012

Protein Kinase C Isozymes as Potential Targets for Anticancer Therapy

Volume:4   Issue: 2
Pp: 125-146
Johann Hofmann
DOI: 10.2174/1568009043481579
Published on: 01 March, 2012

Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications

Volume:4   Issue: 2
Pp: 147-163
Albert F. Kabore, James B. Johnston and Spencer B. Gibson
DOI: 10.2174/1568009043481551
Published on: 01 March, 2012

Transforming Growth Factor-β Superfamily: Evaluation as Breast Cancer Biomarkers and Preventive Agents

Volume:4   Issue: 2
Pp: 165-182
V. Gupta, D. P. Harkin, H. Kawakubo and S. Maheswaran
DOI: 10.2174/1568009043481542
Published on: 01 March, 2012

A Rationale for Inhibiting Progesterone-Related Pathways to Combat Breast Cancer

Volume:4   Issue: 2
Pp: 183-189
Michael R. Moore
DOI: 10.2174/1568009043481515
Published on: 01 March, 2012

Novel Fluoropyrimidines: Improving the Efficacy and Tolerability of Cytotoxic Therapy

Volume:4   Issue: 2
Pp: 191-204
Russell D. Petty and J. Cassidy
DOI: 10.2174/1568009043481533
Published on: 01 March, 2012

Targeted Histone Deacetylase Inhibition for Cancer Therapy

Volume:4   Issue: 2
Pp: 205-218
D. M. Vigushin and R. C. Coombes
DOI: 10.2174/1568009043481560
Published on: 01 March, 2012

AT Islands - Their Nature and Potential for Anticancer Strategies

Volume:4   Issue: 2
Pp: 219-234
Jan M. Woynarowski
DOI: 10.2174/1568009043481524
Published on: 01 March, 2012